Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Haoxi Health Technology (HAO) Receivables - Other (2024 - 2025)

Haoxi Health Technology has reported Receivables - Other over the past 2 years, most recently at $268924.0 for Q2 2025.

  • Quarterly results put Receivables - Other at $268924.0 for Q2 2025, up 2.08% from a year ago — trailing twelve months through Jun 2025 was $268924.0 (up 2.08% YoY), and the annual figure for FY2025 was $268924.0, up 2.08%.
  • Receivables - Other for Q2 2025 was $268924.0 at Haoxi Health Technology, up from $263445.0 in the prior quarter.
  • Over the last five years, Receivables - Other for HAO hit a ceiling of $268924.0 in Q2 2025 and a floor of $263445.0 in Q2 2024.